DLHL
TEVA icon

Donald L. Hagan LLC’s Teva Pharmaceuticals TEVA Stock Holding History

Donald L. Hagan LLC’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-202
Closed -$11K – 280
2016
Q1 		$11K Buy
+202
New +$11.9K 0.01% 269
2015
Q4 		– Sell
-202
Closed -$11K – 277
2015
Q3 		$11K Buy
+202
New +$13.1K 0.01% 278

Other funds holding TEVA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
Lazard Asset Management
Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return
PC
PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Donald L. Hagan LLC's TEVA Position: Q2 2016 in Review

Donald L. Hagan LLC sold out of Teva Pharmaceuticals (TEVA) in Q2 2016, closing a stake of 202 shares — an estimated $11K sold.

Donald L. Hagan LLC first reported a position in TEVA in Q3 2015 and held it in 2 quarters. The position peaked at $11K in Q1 2016. 812 funds tracked by Wall St. Rank hold TEVA as of Q2 2016.

  • Donald L. Hagan LLC reported no remaining Teva Pharmaceuticals position as of Q2 2016 after selling out during the quarter.
  • Donald L. Hagan LLC sold 202 Teva Pharmaceuticals shares in Q2 2016, an estimated $11K.
  • Donald L. Hagan LLC first reported a position in Teva Pharmaceuticals in Q3 2015 and held it in 2 quarters.
  • Donald L. Hagan LLC's Teva Pharmaceuticals position peaked at $11K in Q1 2016.
  • 812 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2016.

Based on Donald L. Hagan LLC's 13F filing for Q2 2016, filed 21 Jul 2016.